Global Hemophilia Treatment Market size & Forecasting (2017-2028)

The Global Hemophilia Treatment Market size is anticipated to grow at a CAGR of 6.9% during the forecast period. Hemophilia is expected to be a complex disorder. It’s a mostly inherited genetic disease that impairs the body's ability to form blood clots, a process needed to prevent bleeding. The simplest thanks to treating hemophilia are to exchange the missing blood coagulation factor in order that the blood can clot properly.


The key leading players in the market include Baxter International, Inc., Grifols SA, CSL Ltd, Octapharma AG, Novo Nordisk, Kedrion, Pfizer, Inc., Bayer AG, Biogen Idec, Inc., and Hospira, Inc.


https://www.quincemarketinsights.com/industry-analysis/hemophilia-t...

Views: 3

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service